Join us at the most important conferences in 2025.
Our teams of experts will be there to answer all your questions, especially about our Recombinant Insulin and TrypsiNNex®.
We will exhibit at:
- Biologics Manufacturing Asia at Marina Bay Sands Expo & Convention Centre in Singapore, March 12-13, 2025
- World Vaccine Congress US at Walter E Washington Convention Centre in Washington D.C., April 22-24, 2025
- BPI Europe at Congress Center in Hamburg, May 12-15, 2025
- ASGCT at Ernest N. Morial Convention Center in New Orleans, May 13-16, 2025
- BPI International at Hynes Convention Center in Boston, September 16-18, 2025
- ESGCT at Fibes in Sevilla, October 7-10, 2025
- World Vaccine Congress Europe at RAI in Amsterdam, October 13-16, 2025
- Cell at Novotel London West in London, November 11-12, 2025
Our Recombinant Insulin is approved by the FDA and EMA and is a vital ingredient in over 100 therapeutic drugs, revolutionising healthcare worldwide.
TrypsiNNex® is an animal-free, recombinant porcine trypsin that delivers exceptional performance and consistency for highly regulated biopharma manufacturing processes.
